← Back to headlines
Clarivate Stock Jumps 16% Following $600M Sale of Life Sciences Segment
Clarivate's shares surged by 16% after the company announced the sale of its life sciences segment for $600 million. This financial move has significantly impacted the company's market performance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
